Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Tom Frohlich
|
| gptkbp:country |
gptkb:Belgium
|
| gptkbp:developedBy |
therapies targeting the tumor microenvironment
|
| gptkbp:focusesOn |
immuno-oncology
|
| gptkbp:foundedIn |
2019
|
| gptkbp:fundedBy |
gptkb:V-Bio_Ventures
gptkb:Polaris_Partners Droia Ventures Fountain Healthcare Partners |
| gptkbp:headquartersLocation |
gptkb:Leuven,_Belgium
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:website |
https://www.montisbio.com/
|
| gptkbp:bfsParent |
gptkb:Versant_Ventures
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
Montis Biosciences
|